Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers
Public ClinicalTrials.gov record NCT02098369. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers (PELICAN)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and improve health in patients with chronic obstructive pulmonary disease (COPD).
Study identification
- NCT ID
- NCT02098369
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 444 participants
Conditions and interventions
Conditions
Interventions
- Written education material (basic) Behavioral
- Additional education material Behavioral
- PELICAN-Proactive Behavioral
- PELICAN-Reactive Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2015
- Primary completion
- Aug 31, 2016
- Completion
- Sep 30, 2016
- Last update posted
- Aug 5, 2018
2015 – 2016
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Apria Healthcare | Lake Forest | California | 92630 | — |
| Los Angeles Biomedical Research Institute | Torrance | California | 90502 | — |
| National Jewish Health | Denver | Colorado | 80206 | — |
| AlphaNet | Miami | Florida | 33134 | — |
| COPD Foundation | Miami | Florida | 33134 | — |
| University of Illinois Hospital | Chicago | Illinois | 60612 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02098369, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2018 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02098369 live on ClinicalTrials.gov.